Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptide
Justin D. Boyd(Pfizer (United States)), Jean‐Cosme Dodart(Merritt College), Jeanne K. Brooks(Dallas VA Medical Center), Shuang Ding(Chinese Academy of Sciences), Jonathan Wiggins(Dallas VA Medical Center), Jaya Sahni(Dallas VA Medical Center), Yu Sun(En Chu Kong Hospital), Zhi Liu, Hanxin Lu(Dallas VA Medical Center), Matthew S Longo(Dallas VA Medical Center), Brett A. Thibodeaux(Dallas VA Medical Center), Hsiao‐Wen Lin(Rutgers, The State University of New Jersey), Yueh-Ting Hsieh, Shixia Wang(Bioscience Research), Yi‐Pin Chang, Madeline M. Vroom(Kennedy Space Center)
Cited by 2
Related Papers
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
|Nature Neuroscience|2002|858
Optimizing the Cell Painting assay for image-based profiling
|Nature Protocols|2023|156
JUMP Cell Painting dataset: morphological impact of 136,000 chemical and genetic perturbations
|bioRxiv (Cold Spring Harbor Laboratory)|2023|101
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
|DOAJ (DOAJ: Directory of Open Access Journals)|2022|76
MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling
|Journal of Clinical Investigation|2016|72